CYT
Cyteir Therapeutics, Inc. Common Stock
CYT
CYT
Delisted
CYT was delisted on the 15th of March, 2024.
45 hedge funds and large institutions have $56.8M invested in Cyteir Therapeutics, Inc. Common Stock in 2022 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 8 increasing their positions, 15 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less capital invested
Capital invested by funds: $ → $
47% less repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 15
Holders
45
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$5.47M | |
| 2 | +$1.81M | |
| 3 | +$1.07M | |
| 4 |
Renaissance Technologies
New York
|
+$746K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$678K |
Top Sellers
| 1 | -$12.6M | |
| 2 | -$6.49M | |
| 3 | -$1.88M | |
| 4 |
BlackRock
New York
|
-$1.38M |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
-$443K |